Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well flavopiridol works in treating patients with chronic
lymphocytic leukemia or prolymphocytic leukemia. Drugs used in chemotherapy, such as
flavopiridol, work in different ways to stop the growth of cancer cells, either by killing
the cells or by stopping them from dividing